• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bilateral synchronous testis tumors of different histology in a patient with the acquired immunodeficiency syndrome related complex.

作者信息

Roehrborn C G, Worrell J T, Wiley E L

机构信息

Division of Urology and Surgical Pathology, University of Texas Southwestern Medical Center, Dallas.

出版信息

J Urol. 1990 Aug;144(2 Pt 1):353-5. doi: 10.1016/s0022-5347(17)39454-5.

DOI:10.1016/s0022-5347(17)39454-5
PMID:2165183
Abstract

The incidence of bilateral testis tumors is approximately 1.5%. Of these cases the majority have the same histological status and few occur synchronously. Recently, an increased number of nonseminomatous germ cell tumors have been reported in the acquired immunodeficiency syndrome population. We describe a rare case of bilateral synchronous testis tumors of different histological status (seminoma and embryonal cell carcinoma) in a patient with the acquired immunodeficiency syndrome related complex. The patient was managed with bilateral orchiectomy and retroperitoneal lymph node dissection. Pathological stage was B1. The treatment was complicated by the fact that the patient is on azidothymidine, a drug that causes bone marrow suppression as a side effect. Because of persistent neutropenia no chemotherapy was given. The patient had no evidence of disease almost 1 year after retroperitoneal lymph node dissection.

摘要

相似文献

1
Bilateral synchronous testis tumors of different histology in a patient with the acquired immunodeficiency syndrome related complex.
J Urol. 1990 Aug;144(2 Pt 1):353-5. doi: 10.1016/s0022-5347(17)39454-5.
2
Simultaneous bilateral testicular germ cell tumors with dissimilar histology. Case report and review of the literature.组织学不同的双侧同时性睾丸生殖细胞肿瘤。病例报告及文献复习。
Urol Int. 1988;43(5):305-9. doi: 10.1159/000281362.
3
[A case of bilateral germ cell tumor of the testis].[一例双侧睾丸生殖细胞肿瘤]
Hinyokika Kiyo. 1989 Nov;35(11):1961-4.
4
Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?睾丸 I 期非精原细胞瘤生殖细胞肿瘤:问题多于答案?
Hematol Oncol Clin North Am. 2011 Jun;25(3):517-27,viii. doi: 10.1016/j.hoc.2011.03.013.
5
Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.化疗后腹膜后淋巴结清扫术治疗晚期生殖细胞肿瘤患者纤维化/坏死的临床结果。
J Urol. 2017 Feb;197(2):391-397. doi: 10.1016/j.juro.2016.09.113. Epub 2016 Oct 5.
6
Synchronous bilateral primary germ cell tumors of the testis: a case report and review of the literature.睾丸同步双侧原发性生殖细胞肿瘤:一例报告并文献复习
J Surg Oncol. 1983 Jan;22(1):59-61. doi: 10.1002/jso.2930220116.
7
[Questions about retroperitoneal lymphadenectomy in the management of childhood testicular germ cell tumors].[关于儿童睾丸生殖细胞肿瘤治疗中腹膜后淋巴结清扫术的问题]
Orv Hetil. 1985 Dec 15;126(50):3085-6.
8
Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.腹膜后淋巴结清扫术后临床Ⅰ期非精原细胞瘤性生殖细胞睾丸肿瘤的原始和复查的血管侵犯和其他预后参数的一致性和预测能力。
J Urol. 2011 Oct;186(4):1298-302. doi: 10.1016/j.juro.2011.05.070. Epub 2011 Aug 17.
9
Bilateral testicular germ cell tumors. Report of nine cases and review of the literature.双侧睾丸生殖细胞肿瘤。9例报告并文献复习
Cancer. 1986 Mar 15;57(6):1254-8. doi: 10.1002/1097-0142(19860315)57:6<1254::aid-cncr2820570632>3.0.co;2-2.
10
[Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].[化疗后腹膜后淋巴结清扫术的临床结果及预测睾丸晚期非精原细胞瘤腹膜后组织学情况]
Zhonghua Wai Ke Za Zhi. 2017 Aug 1;55(8):603-607. doi: 10.3760/cma.j.issn.0529-5815.2017.08.010.